Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arzerra in older patients with untreated indolent B-cell lymphoma
NCT01263418Phase 2Withdrawn
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Jun 2011
- Primary completion
- Jan 2016
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of ofatumumab in follicular lymphoma (FL), marginal zone lymphoma (MZL), sponsored by UNC Lineberger Comprehensive Cancer Center. Planned start Jun 2011; status: withdrawn.
02
Drugs
ofatumumab
03
Conditions
follicular lymphoma (FL)marginal zone lymphoma (MZL)
Beyond the preview
Go deeper on NCT01263418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01263418.